These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 18763266)

  • 1. Effect of neoadjuvant chemotherapy on circumferential margin positivity and its impact on prognosis in patients with resectable oesophageal cancer (Br J Surg 2008; 95: 191-194).
    Andriessen MJ; van der Peet DL; Cuesta MA
    Br J Surg; 2008 Oct; 95(10):1305-6; author reply 1306. PubMed ID: 18763266
    [No Abstract]   [Full Text] [Related]  

  • 2. The degree of circumferential tumour involvement as a prognostic factor in oesophageal cancer.
    Sillah K; Pritchard SA; Watkins GR; McShane J; West CM; Page R; Welch IM
    Eur J Cardiothorac Surg; 2009 Aug; 36(2):368-73. PubMed ID: 19318270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of neoadjuvant chemoradiotherapy on angiogenesis in oesophageal cancer (Br J Surg 2003; 90: 1373-1378).
    Ziprin P; Clarke J
    Br J Surg; 2004 Feb; 91(2):253-4. PubMed ID: 14760683
    [No Abstract]   [Full Text] [Related]  

  • 4. Neoadjuvant chemotherapy and surgery for esophageal adenocarcinoma: prognostic value of circumferential resection margin and stratification of N1 category.
    Saha AK; Sutton C; Rotimi O; Dexter S; Sue-Ling H; Sarela AI
    Ann Surg Oncol; 2009 May; 16(5):1364-70. PubMed ID: 19252949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy.
    Miyata H; Yoshioka A; Yamasaki M; Nushijima Y; Takiguchi S; Fujiwara Y; Nishida T; Mano M; Mori M; Doki Y
    Cancer; 2009 Jul; 115(14):3324-34. PubMed ID: 19452547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Closing the loop around esophagectomy after neoadjuvant therapy.
    Demeester SR
    Ann Surg; 2009 Sep; 250(3):500; author reply 500. PubMed ID: 19730188
    [No Abstract]   [Full Text] [Related]  

  • 7. Delaying surgery after neoadjuvant chemoradiotherapy for rectal cancer may reduce postoperative morbidity without compromising prognosis.
    Kerr SF; Norton S; Glynne-Jones R
    Br J Surg; 2008 Dec; 95(12):1534-40. PubMed ID: 18942057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oesophagectomy for tumours and dysplasia of the oesophagus and gastro-oesophageal junction.
    Epari K; Cade R
    ANZ J Surg; 2009 Apr; 79(4):251-7. PubMed ID: 19432710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Death-associated protein kinase (DAPK) promoter methylation and response to neoadjuvant radiochemotherapy in esophageal cancer.
    Brabender J; Arbab D; Huan X; Vallböhmer D; Grimminger P; Ling F; Neiss S; Bollschweiler E; Schneider PM; Hölscher AH; Metzger R
    Ann Surg Oncol; 2009 May; 16(5):1378-83. PubMed ID: 19224282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular biological challenges in he treatment of esophageal adenocarcinoma.
    Boonstra JJ; Dinjens WN; Tilanus HW; Koppert LB
    Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):275-86. PubMed ID: 19072420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response evaluation by endoscopy, rebiopsy, and endoscopic ultrasound does not accurately predict histopathologic regression after neoadjuvant chemoradiation for esophageal cancer.
    Schneider PM; Metzger R; Schaefer H; Baumgarten F; Vallbohmer D; Brabender J; Wolfgarten E; Bollschweiler E; Baldus SE; Dienes HP; Hoelscher AH
    Ann Surg; 2008 Dec; 248(6):902-8. PubMed ID: 19092334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?
    Elsaleh H; Farrell JJ; Crane CH
    J Gastroenterol Hepatol; 2009 May; 24(5):708-10. PubMed ID: 19646012
    [No Abstract]   [Full Text] [Related]  

  • 13. Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases.
    Gallagher DJ; Zheng J; Capanu M; Haviland D; Paty P; Dematteo RP; D'Angelica M; Fong Y; Jarnagin WR; Allen PJ; Kemeny N
    Ann Surg Oncol; 2009 Jul; 16(7):1844-51. PubMed ID: 19224284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multimodal therapy of esophageal cancer].
    Hartwig W; Strobel O; Lordick F; Büchler MW; Werner J
    Z Gastroenterol; 2008 Oct; 46(10):1207-13. PubMed ID: 18937192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contributions of chemotherapy in the treatment of carcinoma of the esophagus: results and commentary.
    Ajani JA
    Semin Oncol; 1994 Aug; 21(4):474-82. PubMed ID: 8042045
    [No Abstract]   [Full Text] [Related]  

  • 16. Neoadjuvant chemoradiotherapy in esophageal cancer: is it still the question?
    Pereira B; Gourgou-Bourgade S; Azria D; Ychou M
    J Clin Oncol; 2008 Nov; 26(31):5133-4; author reply 5134. PubMed ID: 18838699
    [No Abstract]   [Full Text] [Related]  

  • 17. [A case of severe electrolytic disorder after adjuvant chemotherapy for esophageal cancer].
    Fukuhara K; Omura T; Katsuragi K; Osugi H; Lee S; Kishida S
    Gan To Kagaku Ryoho; 2009 Aug; 36(8):1359-61. PubMed ID: 19692779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer.
    Miyoshi N; Yano M; Takachi K; Kishi K; Noura S; Eguchi H; Yamada T; Miyashiro I; Ohue M; Ohigashi H; Sasaki Y; Ishikawa O; Doki Y; Imaoka S
    J Surg Oncol; 2009 Apr; 99(5):302-6. PubMed ID: 19170110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overall survival with cisplatin and 5-fluorouracil neoadjuvant treatment in patients with esophageal cancer: single-center experience.
    Idelevich E; Buyevich V; Machlenkin S; Ziv-Sokolovsky N; Dinerman M; Brenner B; Kashtan H
    Onkologie; 2008 Dec; 31(12):673-7. PubMed ID: 19060505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early impact of centralization of oesophageal cancer surgery services (Br J Surg 2004; 91: 1630-1632).
    Ng WT
    Br J Surg; 2005 May; 92(5):654. PubMed ID: 15852417
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.